| Summary: | 碩士 === 臺北醫學大學 === 護理學系 === 91 === The purpose of this pilot study is to examine the effects of walking program on reducing fatigue in acute myelogenous leukemia (AML) patients receiving chemotherapy. We used a longitudinal repeated-measure quasi-experimental research design for this study. The eligible subjects were AML patients who received chemotherapy. Patients were recruited using convenient sampling from a medical center in Middle Taiwan. Patients in the training group (n=7) had a 10-minute walk daily for 5 days a week (including test day) after chemotherapy. The training program continued for 3 weeks. The heart rate during training was controlled below the resting heart rate per minute plus 30 (HRresting + 30). 8 patients were in the control group. All patients were interviewed four times: on the first day of chemotherapy (before treatment), and on the 7th, 14th, and 21st day after chemotherapy. We used the following instruments to measure the variables: 12-min walking test, Brief Fatigue Inventory (BFI), Symptom Distress Scale- Chinese Modified Form (SDS-CMF), Profile of Mood States (POMS)- Anxiety and Depression subscales, and vital signs measurement.
Data were analyzed using descriptive analyses, Chi-square test, t test, Shapiro-Wilk normality test, and two / one factor repeated measure ANOVA. The distance of 12-min walk increased 35% in the training group, and decreased 26% in the control group. The improving effects of the training group is better than that of the control group on the degree of fatigue, the degree of ADL interference of fatigue, symptom distress, and mood disturbance.
Even though our data did not show a significant difference between the training and control groups due to the small sample size, we did find an agreement with most current exercise interventions studies supporting the benefits of activity/exercise during cancer treatment. In conclusions, proper walking activity may help to reduce fatigue while the cancer inpatients during chemotherapy.
|
|---|
